Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Andrew Gwynne on 2016-03-01.

To ask the Secretary of State for Health, with reference to page 24 of the Accelerated Access Review, published in October 2015, what steps he is taking to ensure that drugs that target the genetically validated targets (a) PCSK9 and (b) BCL2 are introduced into routine NHS care; and if he will make a statement.

Ben Gummer

The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government on reforms to accelerate access for National Health Service patients to innovative medicines and medical technologies making our country the best place in the world to design, develop and deploy these products. The terms of the reference for the review focus on faster access to innovations, which may include drugs that target genetically validated targets such as PCSK9 and BCL2.